Product Program year 2023 Source: CMS Open Payments

Viekira Pak

Drug Virology

NDC 0074-3093-28

Open in the dashboard

General payments

$70,013

47 payments

Research payments

$13,000

1 payment

Through program year 2023, $70,013 in general payments and $13,000 in research payments were reported against Viekira Pak (Virology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2023 Research $13,000 1
2022 General $189 9
2020 General $9,905 14
2019 General $59,919 24

Breakdown

Who paid General payments · program years 2019–2022
  1. AbbVie, Inc. $70,013 47 payments
Top recipients General payments · program year 2022
  1. Robert Rahimi Hepatology · Dallas, TX $21 11% · 1 payment
  2. Sumeet Asrani Transplant Hepatology · Dallas, TX $21 11% · 1 payment
  3. Jamil Alsahhar Gastroenterology · Dallas, TX $21 11% · 1 payment
  4. Amar Mahgoub Transplant Hepatology · Dallas, TX $21 11% · 1 payment
  5. Saleh Elwir Gastroenterology · Dallas, TX $21 11% · 1 payment

The top 5 of 9 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Gastroenterology Internal Medicine $63 33% · 3 practitioners
  2. Transplant Hepatology Internal Medicine $42 22% · 2 practitioners
  3. Hepatology Internal Medicine $21 11% · 1 practitioner
  4. Nurse Practitioner, Adult Health Nurse Practitioner $21 11% · 1 practitioner
  5. Physician Assistant $21 11% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Texas $147 78% · 7 recipients
  2. Pennsylvania $21 11% · 1 recipient
  3. Tennessee $21 11% · 1 recipient

Each share is of general payments naming this product in 2022 where a state was reported.

47 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record